APA (7th ed.) Citation

L, W., Y, W., & Q, Z. (2026). Economic evaluation of sodium-glucose transporter 2 inhibitors compared with glucagon-like peptide 1 receptor agonist for the treatment of type 2 diabetes: A systematic review. European journal of clinical pharmacology, 82(4), . https://doi.org/10.1007/s00228-026-04015-9

Chicago Style (17th ed.) Citation

L, Wang, Wang Y, and Zhao Q. "Economic Evaluation of Sodium-glucose Transporter 2 Inhibitors Compared with Glucagon-like Peptide 1 Receptor Agonist for the Treatment of Type 2 Diabetes: A Systematic Review." European Journal of Clinical Pharmacology 82, no. 4 (2026). https://doi.org/10.1007/s00228-026-04015-9.

MLA (9th ed.) Citation

L, Wang, et al. "Economic Evaluation of Sodium-glucose Transporter 2 Inhibitors Compared with Glucagon-like Peptide 1 Receptor Agonist for the Treatment of Type 2 Diabetes: A Systematic Review." European Journal of Clinical Pharmacology, vol. 82, no. 4, 2026, https://doi.org/10.1007/s00228-026-04015-9.